Long-term cognitive and functional decline in late onset Alzheimer's disease: therapeutic implications.
National Institute of Clinical Excellence guidelines advocate the use of the Mini-Mental Test Examination and a functional assessment as a means of measuring treatment response. However, there is little knowledge of the change expected in those with Alzheimer's disease in clinical practice. to describe the long-term variability of the Mini-Mental Test Examination and Blessed Dementia Rating Scale. 374 Alzheimer's disease patients referred to psychiatric services in southeast London were followed annually over a 3-year period. the mean Mini-Mental Test Examination score for the total group at baseline was 9.9 points. Individual variability in the rate of cognitive and functional decline is large and around 40% of patients after 1 year, and up to one-quarter of patients after 3 years who survived, show no change or an improvement in scores compared with baseline measures. in the evaluation of individual treatment response the rate of change, as measured by the Mini-Mental Test Examination and Blessed Dementia Rating Scale, is of limited value.